Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
TP-04 by Tarsus Pharmaceuticals for Rosacea: Likelihood of Approval
TP-04 is under clinical development by Tarsus Pharmaceuticals and currently in Phase II for Rosacea. According to GlobalData, Phase II...